TAG:
medicare billing
OIG Moves to Address “Usual Charge” Issue
By Robert Michel | From the Volume X No. 14 – October 20, 2003 Issue
CEO SUMMARY: Federal regulators are taking another crack at defining “usual charges.” Language in the proposed rules published last month precisely defines which payers should be included in determining “usual charges” and what charge basis to use for specific payers. Once effecti…
Tenet’s Outlier Medicare Fees Put It in Unwelcome Spotlight
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
MEDICARE CODING AND BILLING policies at Tenet Healthcare Corporation have come under scrutiny by both Medicare officials and Wall Street analysts. Attention is centered around how Tenet aggressively pursued Medicare reimbursement under “outlier” formulas. These formulas are designed to supplemen…
Specialty Lab’s Woes Trigger Big Market Shift
By R. Lewis Dark | From the Volume IX No. 9 – June 24, 2002 Issue
IT’S THE UNPUBLICIZED STORY BEHIND THE STORY. Most of the laboratory industry knows that Specialty Laboratories, Inc. is the target of sanctions issued by both federal and state laboratory regulators. But the impact of this development has yet to be recognized across the industry. …
Specialty Labs Coping With Unique Challenges
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: Few laboratory executives have ever been tested as intensely as those of Specialty Laboratories, Inc. Since the first of the year, Quest Diagnostics Incorporated has purchased two of its biggest lab clients. In April, state and federal lab regulators issued sanctions. Both de…
State, Federal Regulators Target Specialty Labs
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Specialty Laboratories, Inc. has earned the dubious honor of being the first-ever publicly-traded laboratory to have its CLIA-88 license revoked by federal regulators, terminating its right to payment for services covered by Medicare and Medicaid. The revocation is slated to …
DIANON Systems, UroCor, Cytyc, Digene, McKesson HBOC, Abaton.com, Abbott
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
FEDERAL ATTORNEY SERVES SUBPOENA ON DIANON SYSTEMS NEWS BROKE LAST WEEK that DIANON Systems, Inc. had received a subpoena from the U.S. Attorney’s Office in Connecticut for documents relating to laboratory billing. Apparently “LabScam” is still alive …
Medicare Refund Request Issued To AmeriPath, Inc
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
CEO SUMMARY: Regulators believe AmeriPath’s Ft. Lauderdale laboratory submitted claims during 1996 which were based upon improper procedure codes or lacked adequate documentation. AmeriPath “vigorously” disputes the situation. It is still uncertain as to whether this action represen…
1997’s Top Ten Lab Stories Predict New Directions
By Robert Michel | From the Volume IV No. 18 – December 29, 1997 Issue
CEO SUMMARY: Events during 1997 reveal that the laboratory industry continues to undergo fundamental change. Yet even amidst the industry’s downsizing, selected laboratory organizations continue to flourish. Here is THE DARK REPORT’s annual look at top stories for the year. A careful …
Ohio Hospital Lab Lawsuit Tossed Out By The Judge
By Robert Michel | From the Volume IV No. 14 – October 6, 1997 Issue
CEO SUMMARY: Hospitals in Ohio now find themselves at square one again in their efforts to stop federal prosecutors from continuing the statewide investigation of laboratory billing practices. The judge’s legal ruling denied jurisdiction to hear the case and did not address any of the a…
Making $1 Billion Disappear
By R. Lewis Dark | From the Volume IV No. 6 – April 21, 1997 Issue
MOST PEOPLE WOULD AGREE WITH ME THAT $1 BILLION IS A HUGE AMOUNT of money. It generally takes the federal government to squander amounts that big. The Internal Revenue Service’s $2 billion computer boondoggle is the latest example of government incompetence with taxpayers’ money…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized